Melatonin Physiology

Melatonin (N-acetyl-5-methoxytryptamine) is a ubiquitous indoleamine hormone primarily synthesized by the pineal gland in vertebrates. First isolated from bovine pineal extract in 1958 by Aaron B. Lerner and colleagues, melatonin has since been recognized as a central regulator of circadian rhythms, sleep-wake cycles, and numerous extrapineal physiological processes¹. While historically classified strictly as a chronobiotic, contemporary research positions melatonin as a multifunctional signaling molecule with antioxidant, immunomodulatory, and oncostatic properties².

Biosynthesis & Metabolism

Melatonin synthesis occurs primarily within pinealocytes and follows a three-step enzymatic pathway originating from dietary tryptophan:

1. Tryptophan hydroxylase (TPH) converts tryptophan to 5-hydroxytryptophan (5-HTP).
2. Aromatic L-amino acid decarboxylase (AADC) decarboxylates 5-HTP to serotonin (5-hydroxytryptamine, 5-HT).
3. N-acetyltransferase (AANAT), the rate-limiting enzyme, acetylates serotonin to N-acetylserotonin.
4. Hydroxyindole-O-methyltransferase (HIOMT/ASMT) methylates N-acetylseratonin to form melatonin.

Following secretion into the systemic circulation, melatonin undergoes rapid hepatic metabolism, primarily via cytochrome P450 1A2 (CYP1A2), yielding 6-hydroxymelatonin, which is subsequently conjugated with sulfate or glucuronic acid and excreted in urine. The short plasma half-life necessitates sustained-release formulations for therapeutic chronobiotic applications³.

Circadian Regulation

Pineal melatonin synthesis is tightly governed by the suprachiasmatic nucleus (SCN) of the hypothalamus, the master circadian pacemaker. Light information enters via the retinohypothalamic tract (RHT) and modulates SCN neuronal firing. During darkness, the SCN activates a polysynaptic pathway: paraventricular nucleus (PVN) → intermediolateral cell column (IML) → superior cervical ganglion (SCG) → pineal gland. This sympathetic outflow releases norepinephrine, which binds to β-adrenergic receptors on pinealocytes, elevating cAMP and phosphorylating AANAT, thereby triggering nocturnal melatonin surges⁴.

Light exposure during the dark phase suppresses AANAT activity via cGMP-dependent pathways, effectively shutting down melatonin production. This light-dependent gating ensures that melatonin rhythms precisely mirror the geophysical day–night cycle, serving as an endogenous "darkness signal"

Receptors & Signaling

Melatonin exerts its effects primarily through two high-affinity G-protein-coupled receptors (GPCRs): MT₁ (Mel1a) and MT₂ (Mel1b). Both receptors are widely expressed in the CNS and peripheral tissues, though their distribution and downstream signaling differ:

Additional binding sites include orphan receptors (MT₃/5-HT_1A) and cytosolic retinoid-related orphan receptor gamma (RORγt), though the latter's physiological relevance remains debated⁵.

Physiological Roles

Circadian Entrainment & Sleep

Melatonin's most established role is the entrainment of peripheral circadian oscillators to the central SCN clock. Administration of exogenous melatonin at specific times of day produces phase-advancing or phase-delaying shifts in the circadian rhythm, characterized by the melatonin phase response curve (PRC). Peak effectiveness for phase advancement occurs during the late night, while phase delays are maximized in the late afternoon/early evening⁶.

Antioxidant & Cytoprotective Effects

Melatonin acts as a direct free radical scavenger, neutralizing hydroxyl radicals, singlet oxygen, and peroxynitrite. Unlike vitamin C or E, melatonin is not oxidized into pro-oxidant species upon reaction. It also upregulates endogenous antioxidant enzymes (superoxide dismutase, glutathione peroxidase, catalase) and stimulates mitochondrial biogenesis via PGC-1α signaling⁷.

Immunomodulation & Reproduction

In many seasonal breeders, melatonin duration encodes day length, regulating gonadotropin-releasing hormone (GnRH) pulsatility and reproductive cycles. In humans, melatonin modulates NK cell cytotoxicity, macrophage phagocytosis, and cytokine production (e.g., IL-2, TNF-α). Chronic sleep deprivation or circadian disruption diminishes these immunomodulatory effects, potentially increasing susceptibility to infections and inflammatory disorders.

Extrapineal Production

While pineal-derived melatonin dominates systemic circulation, extrapineal tissues—including the gastrointestinal tract (especially enterochromaffin-like cells), retina, bone marrow, keratinocytes, and leukocytes—possess complete melatonin-synthesizing machinery. Extrapineal melatonin operates via autocrine or paracrine mechanisms, regulating local physiology such as gut barrier integrity, retinal photoprotection, hematopoiesis, and skin wound healing⁸.

Clinical Implications

Pharmacological melatonin is FDA-approved for delayed sleep phase disorder (DSPD) and used off-label for jet lag, shift work sleep disorder, and pediatric sleep onset insomnia. Typical therapeutic doses range from 0.5–5 mg, taken 30–120 minutes before desired sleep onset. Higher doses (>10 mg) do not improve efficacy and may cause次日 grogginess, headache, or transient hypothermia⁹.

Emerging research explores melatonin's role in neuroprotection (Parkinson's, Alzheimer's), cancer adjunct therapy, and metabolic syndrome management, though large-scale randomized controlled trials remain limited. The Aevum Encyclopedia continuously updates this entry as peer-reviewed evidence matures.